Table: begin end state 1 16 cytoplasmic 17 35 transmembrane 36 39 non-cytoplasmic 40 61 transmembrane 62 69 cytoplasmic 70 91 transmembrane 92 113 non-cytoplasmic 114 143 transmembrane 144 150 cytoplasmic 151 169 transmembrane 170 188 non-cytoplasmic 189 211 transmembrane 212 238 cytoplasmic 239 260 transmembrane 261 278 non-cytoplasmic 279 297 transmembrane 298 316 cytoplasmic 317 340 transmembrane 341 345 non-cytoplasmic 346 365 transmembrane 366 371 cytoplasmic 372 391 transmembrane 392 397 non-cytoplasmic 398 420 transmembrane 421 431 cytoplasmic 432 456 transmembrane 457 458 non-cytoplasmic
Input: >BPHYT_RS34710 MHLTTTLAPWSSHDTQLILSCVLGLALIIVFISVLKLAPFLSILVGTFAAGFAAGLPLEA VASAFTKGAGALLGDVGIIIALGAMLGALMAESGAADRLVSTILKHSTPRTLPWMMAVVA LIIGLPLFFEVGLVMMVPIIFVMARRSQQPILRIAIPALAGMTTLHALLPPHPGPLIAVS ALHADLGLTLGLGLIVAIPAVILAGPLYGIWLSKRMHVVEPEEMGKLFSAKQDTGEPPGF AISLITILLPVVLMLGRTVAKLLLQPESFLFNTLNFLGEPLVALGLTVLFAVVALGWSRG MARERVGGILRKSLPPIAALLLTIGAGGGLKQALVVAGISSTIGKIAVGAHMPLILLAWL IAVALRQATGSATVATTTTAGIVAPVVAGLSATHNSLMALAIGAGSVFFCHVNDAGFWMV REYFGLQLKQTVLVWSVLQTIVSVVGLALTLVLWTLLT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server